Actor Samantha Akkineni has participated within the #SorrySara and #SorryRakul on-line pattern, after a report by a information channel stated that the 2 actors had been named by Rhea Chakraborty as customers of medication. The declare has since been rejected by the Narcotics Management Bureau, prompting social media customers to apologise to the 2 actors for the misreporting.
On Instagram tales, Samantha shared a put up about Sara Ali Khan and Rakul Preet Singh not being summoned, and wrote, “#SorryRakul, #SorrySara.”
Occasions Now had beforehand reported that Rhea Chakraborty, throughout interrogation, had named Sara, Rakul and clothier Simone Khambhatta, amongst others, as drug customers. The report claimed that the NCB had ready an inventory of 25 Bollywood names who can be summoned for additional questioning.
NCB deputy director KPS Malhotra, informed Free Press Journal that no Bollywood names have been listed to be summoned. He stated, “We’ve got not ready any Bollywood checklist. The checklist earlier ready was of peddlers and traffickers. It’s getting confused with Bollywood. The names haven’t been zeroed upon.”
Additionally learn: Shibani Dandekar, sister Anusha delete posts calling for launch of Rhea Chakraborty
Rhea, her brother Showik, Samuel Miranda, Dipesh Swant, Abdul Basit and Zaid Vilatra have all been arrested on drugs-related expenses within the ongoing investigation into Sushant Singh Rajput’s loss of life. Rhea has been accused by Sushant’s household of getting abetted the actor’s suicide and misappropriated his funds. She is at present on the Byculla Jail.
Rhea was additionally reported to have informed the NCB that Sushant used to smoke marijuana, and that he began smoking whereas filming Kedarnath, which additionally starred Sara. “Sure, Sushant used to smoke marijuana, he used to take it even earlier than he met me. He began this throughout Kedarnath. I used to regulate him on this division solely. He was a person of his personal selections and no one might cease him,” she informed Aaj Tak in an interview.